Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.
about
Dysphagia Management and Stroke UnitsAssessment of cognitive safety in clinical drug developmentAnticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic reviewCumulative use of strong anticholinergics and incident dementia: a prospective cohort studyDrugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysisA predictive in vitro model of the impact of drugs with anticholinergic properties on human neuronal and astrocytic systemsNew horizons: the management of hypertension in people with dementia.Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data.Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.CUA guideline on adult overactive bladderTurning over the rocks: role of anticholinergics and benzodiazepines in cognitive decline and falls.Physical activity, cognitive function, and brain health: what is the role of exercise training in the prevention of dementia?Developing a framework for a novel multi-disciplinary, multi-agency intervention(s), to improve medication management in community-dwelling older people on complex medication regimens (MEMORABLE)--a realist synthesis.Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycleDrug Burden Index in older adults: theoretical and practical issues.Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reportsUnintended effects of cardiovascular drugs on the pathogenesis of Alzheimer's diseaseEffect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.Cognitive decline in older persons initiating anticholinergic medications.Adverse cognitive effects of medications: turning attention to reversibility.Effect of pharmacological treatment for urinary incontinence in the elderly and frail elderly: A systematic review.Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.Care transitions: a leverage point for safe and effective medication use in older adults--a mini-reviewReconsideration of key articles regarding medication-related problems in older adults from 2011.Does depression impact cognitive impairment in patients with heart failure?Concordance Between Anticholinergic Burden ScalesAntidepressant Use and Cognitive Decline: The Health and Retirement StudyMeasuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measuresPlacebo analgesia: cognitive influences on therapeutic outcome.Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients.Anticholinergic Exposure During Rehabilitation: Cognitive and Physical Function Outcomes in Patients with Delirium Superimposed on DementiaClinical impact of potentially inappropriate medications during hospitalization of acutely ill older patients with multimorbidity.Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal womenThe Influence of Patient Characteristics on Anticholinergic Events in Older People.Patients Aged 80 Years or Older are Encountered More Potentially Inappropriate Medication UseLong-term anticholinergic use and the aging brain.Ten-year trajectory of potentially inappropriate medications in very old women: importance of cognitive statusAssociation Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older AdultsOver-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults.
P2860
Q28079563-5C0E3858-C5E9-4E22-94C7-E270806ECAA8Q28084637-2CC0A4FE-6590-4A6F-8B76-892D18C902E8Q28085414-E85D539F-A683-4D9D-986A-906E48240D97Q28255929-9CD4CA0E-41A6-49BF-9336-70F2980BA9A4Q28258219-C923B930-1580-4CE1-8A5F-9F7AFC623EF8Q28543817-AF6003AB-2565-4BDE-B902-4BB1D30D3E12Q30241411-478B75A4-F2CF-453B-B9BF-CEA9B5DB5C68Q30714318-2D3A001B-767C-427B-9F5C-07F7CCEB5A9BQ31155412-30500480-72D7-4733-8120-79AB501FF5EBQ33665026-33698DFD-ABF8-4931-9BDA-6AD6D3BAF84CQ33715169-71B0066E-0886-4DDF-BA2A-BEEBD28BD397Q33772036-00F14DEA-BAE5-4513-BC42-C04C7A02173CQ33869278-E8260581-28A2-4B16-8A10-241D28C1DA27Q33949454-40425050-A744-4AA1-A1DE-A6C13BD24C99Q34198674-3EE2D4BC-C7C3-4827-B933-4D1BEE6CAA91Q34269392-86DA2274-52CA-420B-BBAD-65BF5275B609Q34350595-E68CE2A3-7E23-4960-8691-11A1E63CA417Q34429787-D81BC3C5-D16B-4A83-86F0-E1449458D883Q34521956-E282E763-3A30-4EA8-9B0A-F80DE006C531Q34760402-24234EB3-E6B7-48BA-AD6D-2850D3531183Q35137757-62244711-76C6-459F-9162-672DDFA0D509Q35556196-9719FE78-D409-4150-A57F-C317DA39A6A6Q35688580-EAAC695E-99AE-4D98-AAC6-03ADF038ED1EQ35775812-2B8A56DE-3F36-4337-91F9-385E24BE63FFQ36043785-E6151FD1-6A62-451D-8BF0-C9FA5EDFDF59Q36167914-505954DD-2B98-418A-B0E1-7D9FE5E686D7Q36197055-AC72BA92-9462-4E26-8246-DE62F9F3E209Q36201714-74800E91-B26C-44A6-9CB8-4E85D7BE3A8CQ36243682-F455FFAD-FE27-413F-99C1-D03DBABEE6C2Q36245753-5B755B59-6E43-44B9-9BDD-8261510D2CEEQ36277027-2A5C0DC7-2215-4094-9129-2CE264D212A9Q36405464-CCD0B58A-711C-4BDB-AA31-83865EDE5924Q36572066-28BB355B-A50B-452E-85FE-BED0A6F42F6EQ36611322-1C364589-9D58-4612-86BA-2259D2E8BDFAQ36650690-DAB7136C-1BE8-4569-BB68-0957D2860C40Q36701688-0EE2638B-2C12-4C5F-8A0C-24869520BA89Q36906645-E1B20CC5-0EB8-4BDA-AF38-FD93CF300C2FQ37226630-80B01B63-B987-4000-AC8F-17C96A2CA105Q37268405-8494EDE3-3D3D-43D4-B399-F4BC8318D9F7Q37446075-6BCCA6BE-6C6B-4CE0-99BB-9CDC5ED61B59
P2860
Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Anticholinergic medication use ...... ive function and ageing study.
@en
Anticholinergic medication use ...... ive function and ageing study.
@nl
type
label
Anticholinergic medication use ...... ive function and ageing study.
@en
Anticholinergic medication use ...... ive function and ageing study.
@nl
prefLabel
Anticholinergic medication use ...... ive function and ageing study.
@en
Anticholinergic medication use ...... ive function and ageing study.
@nl
P2093
P50
P1476
Anticholinergic medication use ...... ive function and ageing study.
@en
P2093
Cornelius Katona
David Smithard
Kathryn Richardson
Malaz A Boustani
P304
P356
10.1111/J.1532-5415.2011.03491.X
P407
P577
2011-06-24T00:00:00Z